K Pharma,Inc.
4896.T · JPX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | ¥7,206,457 | ¥8,355,312 | ¥8,836,163 | ¥10,946,373 |
| - Cash | ¥2,268,198 | ¥3,266,408 | ¥1,336,847 | ¥188,782 |
| + Debt | ¥0 | ¥0 | ¥0 | ¥0 |
| Enterprise Value | ¥4,938,259 | ¥5,088,904 | ¥7,499,316 | ¥10,757,591 |
| Revenue | ¥0 | ¥1,000,000 | ¥0 | ¥0 |
| % Growth | -100% | – | – | – |
| Gross Profit | ¥0 | ¥910,000 | ¥0 | -¥6,803 |
| % Margin | – | 91% | – | – |
| EBITDA | -¥844,104 | ¥366,058 | -¥390,527 | -¥222,315 |
| % Margin | – | 36.6% | – | – |
| Net Income | -¥846,455 | ¥260,330 | -¥392,427 | -¥228,718 |
| % Margin | – | 26% | – | – |
| EPS Diluted | -72.94 | 22.43 | -42.06 | -19.79 |
| % Growth | -425.2% | 153.3% | -112.5% | – |
| Operating Cash Flow | -¥983,719 | ¥454,425 | -¥363,482 | -¥196,320 |
| Capital Expenditures | -¥14,490 | -¥9,803 | -¥29,958 | ¥0 |
| Free Cash Flow | -¥998,209 | ¥444,622 | -¥393,440 | -¥196,320 |